George Elakis

873 total citations
8 papers, 137 citations indexed

About

George Elakis is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, George Elakis has authored 8 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in George Elakis's work include Craniofacial Disorders and Treatments (4 papers), Fibroblast Growth Factor Research (2 papers) and Cleft Lip and Palate Research (2 papers). George Elakis is often cited by papers focused on Craniofacial Disorders and Treatments (4 papers), Fibroblast Growth Factor Research (2 papers) and Cleft Lip and Palate Research (2 papers). George Elakis collaborates with scholars based in Australia and United States. George Elakis's co-authors include Tony Roscioli, Michael F. Buckley, Rachel Susman, Michael F. Buckley, Timothy C. Cox, Mark Johnston, Peter J. Taylor, Julie McGaughran, Christopher G. Bell and Christopher A. Walsh and has published in prestigious journals such as Journal of Medical Genetics, Genetics in Medicine and Genes Chromosomes and Cancer.

In The Last Decade

George Elakis

8 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Elakis Australia 6 94 60 23 17 15 8 137
Michael Kennemer United States 4 92 1.0× 92 1.5× 11 0.5× 23 1.4× 16 1.1× 4 181
J. J. T. van Harssel Netherlands 5 70 0.7× 35 0.6× 8 0.3× 19 1.1× 12 0.8× 5 102
Jennifer Keller‐Ramey United States 8 71 0.8× 62 1.0× 15 0.7× 8 0.5× 7 0.5× 8 162
Leah Fleming United States 5 78 0.8× 74 1.2× 8 0.3× 13 0.8× 6 0.4× 5 128
Monika Weisz Hubshman Israel 6 79 0.8× 108 1.8× 10 0.4× 9 0.5× 8 0.5× 7 165
Cristina Skrypnyk Bahrain 8 95 1.0× 28 0.5× 7 0.3× 20 1.2× 7 0.5× 17 155
Gabrielle Lemire Canada 7 91 1.0× 72 1.2× 5 0.2× 9 0.5× 17 1.1× 16 165
Yah-Huei Wu-Chou Taiwan 8 63 0.7× 65 1.1× 5 0.2× 12 0.7× 10 0.7× 15 146
Dominik S. Westphal Germany 7 82 0.9× 51 0.8× 43 1.9× 6 0.4× 5 0.3× 29 159
Paula Morris United States 7 54 0.6× 34 0.6× 9 0.4× 15 0.9× 8 0.5× 12 179

Countries citing papers authored by George Elakis

Since Specialization
Citations

This map shows the geographic impact of George Elakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Elakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Elakis more than expected).

Fields of papers citing papers by George Elakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Elakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Elakis. The network helps show where George Elakis may publish in the future.

Co-authorship network of co-authors of George Elakis

This figure shows the co-authorship network connecting the top 25 collaborators of George Elakis. A scholar is included among the top collaborators of George Elakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Elakis. George Elakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ma, Alan, Edwin P. Kirk, Conor McClenaghan, et al.. (2019). Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain‐of‐function variant: Initial experience. American Journal of Medical Genetics Part A. 179(8). 1585–1590. 24 indexed citations
2.
Kirk, Edwin P., Kristine Barlow‐Stewart, Arthavan Selvanathan, et al.. (2018). Beyond the panel: preconception screening in consanguineous couples using the TruSight One “clinical exome”. Genetics in Medicine. 21(3). 608–612. 16 indexed citations
3.
James, Paul A., Bronwyn Culling, Mark A. Jenkins, et al.. (2009). Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre–Chotzen syndrome: An Australian multicenter study. Genes Chromosomes and Cancer. 48(7). 533–538. 2 indexed citations
4.
Freeman, Lucinda, George Elakis, Geoff Watson, et al.. (2008). Pfeiffer syndrome with neonatal death secondary to tracheal obstruction owing to the FGFR2 Glu565Ala mutation. Clinical Dysmorphology. 17(3). 223–224. 5 indexed citations
5.
Anderson, Peter J., Timothy C. Cox, Tony Roscioli, et al.. (2007). Somatic FGFR and TWIST Mutations are not a Common Cause of Isolated Nonsyndromic Single Suture Craniosynostosis. Journal of Craniofacial Surgery. 18(2). 312–314. 15 indexed citations
6.
Zankl, Andreas, George Elakis, Rachel Susman, et al.. (2007). Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation. American Journal of Medical Genetics Part A. 146A(2). 212–218. 16 indexed citations
7.
Taylor, Peter J., George Elakis, Christopher A. Walsh, et al.. (2007). Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy. Journal of Medical Genetics. 44(6). 368–372. 41 indexed citations
8.
McGaughran, Julie, Rachel Susman, Michael F. Buckley, et al.. (2006). A case of Beare–Stevenson syndrome with a broad spectrum of features and a review of the FGFR2 Y375C mutation phenotype. Clinical Dysmorphology. 15(2). 89–93. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026